找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Assessment of Cancer Screening; A Primer Pamela M. Marcus Book‘‘‘‘‘‘‘‘ 2022 National Institutes of Health, Cancer Control and Population Sc

[复制链接]
查看: 36562|回复: 47
发表于 2025-3-21 18:41:22 | 显示全部楼层 |阅读模式
期刊全称Assessment of Cancer Screening
期刊简称A Primer
影响因子2023Pamela M. Marcus
视频video
发行地址This book is open access, which means that you have free and unlimited access.Authored by an expert in cancer screening modalities and epidemiology.Focuses on cancer screening through methodology and
图书封面Titlebook: Assessment of Cancer Screening; A Primer Pamela M. Marcus Book‘‘‘‘‘‘‘‘ 2022 National Institutes of Health, Cancer Control and Population Sc
影响因子.Cancer screening is a prominent strategy in cancer control in the United States, yet the ability to correctly interpret cancer screening data eludes many researchers, clinicians, and policy makers. This open access primer rectifies that situation by teaching readers, in simple language and with straightforward examples, why and how the population-level cancer burden changes when screening is implemented, and how we assess whether that change is of benefit. This book provides an in-depth look at the many aspects of cancer screening and its assessment, including screening phenomena, performance measures, population-level outcomes, research designs, and other important and timely topics.. .Concise, accessible, and focused, .Assessment of Cancer Screening: A Primer. is best suited to those with education or experience in clinical research or public health in the United States - no previous knowledge of cancer screening assessment is necessary. This is the first text dedicated to cancer screening theory and methodology to be published in 20 years..
Pindex Book‘‘‘‘‘‘‘‘ 2022
The information of publication is updating

书目名称Assessment of Cancer Screening影响因子(影响力)




书目名称Assessment of Cancer Screening影响因子(影响力)学科排名




书目名称Assessment of Cancer Screening网络公开度




书目名称Assessment of Cancer Screening网络公开度学科排名




书目名称Assessment of Cancer Screening被引频次




书目名称Assessment of Cancer Screening被引频次学科排名




书目名称Assessment of Cancer Screening年度引用




书目名称Assessment of Cancer Screening年度引用学科排名




书目名称Assessment of Cancer Screening读者反馈




书目名称Assessment of Cancer Screening读者反馈学科排名




单选投票, 共有 0 人参与投票
 

0票 0%

Perfect with Aesthetics

 

0票 0%

Better Implies Difficulty

 

0票 0%

Good and Satisfactory

 

0票 0%

Adverse Performance

 

0票 0%

Disdainful Garbage

您所在的用户组没有投票权限
发表于 2025-3-21 22:40:42 | 显示全部楼层
发表于 2025-3-22 03:23:00 | 显示全部楼层
发表于 2025-3-22 07:31:21 | 显示全部楼层
Foundations,ed screening programs and opportunistic screening are compared and their strengths and weaknesses are noted. The most frequently used metrics of benefit of cancer screening are presented along with arguments for and against their use. The reason why efficacy, the ability of cancer screening to lead
发表于 2025-3-22 10:18:23 | 显示全部楼层
Population Measures: Definitions,ver, intermediate outcomes that clearly are not favorable are sufficient evidence that cancer screening will not reduce cause-specific mortality. Chapter 4 presents methods for calculating intermediate and definitive outcomes. Examples and figures are provided to assist in comprehension.
发表于 2025-3-22 16:30:42 | 显示全部楼层
发表于 2025-3-22 18:42:48 | 显示全部楼层
发表于 2025-3-23 00:31:58 | 显示全部楼层
Polish Journalists in the 1980s to detection of cancer, and provide no evidence as to screening’s ability to reduce mortality. Performance measures are rarely considered sufficient evidence to implement cancer screening for the first time, though they have driven dissemination of tests that are thought to represent upgrades of es
发表于 2025-3-23 05:08:35 | 显示全部楼层
Polish Journalists in the 1980scribe characteristics of the detected cancers or experience after diagnosis. For that information, intermediate and definitive outcomes are used. Intermediate and definitive outcomes are called population measures because they incorporate the experience of all cancers, regardless of the method of de
发表于 2025-3-23 06:51:45 | 显示全部楼层
Kent and Synecdochal Native Identity,ant or study researcher. Most RCTs comprise two groups, referred to as trial arms. The intervention arm receives the cancer screening regimen that is under intervention, while the control arm receives no intervention or the current standard of care. The control arm is treated as the counterfactual e
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-18 09:06
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表